Skip to main content

Strive, Inc. Announces Third Quarter 2025 Financial Results

DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) — Strive, Inc. (Nasdaq: ASST) (“Strive” or the “Company”), the first Bitcoin treasury company amplified exclusively with perpetual preferred equity, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights:Consummated the reverse acquisition of Asset Entities Inc. and concurrently raised $762.6 million through PIPE financing transaction and warrant exercises through September 30, 2025, with the opportunity to raise an additional $736.6 million through exercise of remaining warrants. Announced the entry into an agreement and plan of merger for the acquisition of Semler Scientific, Inc. (“Semler”) in an all-stock transaction that would result in Semler being a wholly owned subsidiary of Strive, subject to the satisfaction...

Continue reading

Mawson Infrastructure Group Inc. Reports Third Quarter 2025 Financial Results

MIDLAND, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a U.S.-based technology company that designs, builds, and operates next-generation digital infrastructure platforms providing services to the artificial intelligence (AI), high-performance computing (HPC), and digital assets (including Bitcoin mining), and other intensive compute applications market sectors, announced today its financial and operational results for the three and nine months ended September 30, 2025. Kaliste Saloom, Interim CEO of Mawson, said, “Our third quarter results clearly demonstrate Mawson’s ongoing commitment to growth and our resilience. With significant improvements in revenue, gross profit, and net income, we are making real progress toward sustained profitability. The successful...

Continue reading

TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives

FREDERICK, Md., Nov. 14, 2025 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced financial results for the quarter ended September 30, 2025, and provided an update on strategic initiatives designed to drive long-term growth. Q3 2025 Highlights:Revenue Growth: Revenues of $2.0 million reflecting a 95% sequential increase over Q2 2025, driven primarily by higher equipment purchases and continued strength in our recurring BIT™ Solution sales. Strong Gross Margins: Gross profit margin remained healthy at 61% in Q3, underscoring the efficiency of operations and the value of the Company’s technology. Operational Efficiencies: Reduced selling, research, and...

Continue reading

Femasys Announces Third Quarter Financial Results for 2025

– FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval – – $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway – ATLANTA, Nov. 14, 2025 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the third quarter of 2025. Corporate Highlights from 3Q 2025Announced second partner order for FemBloc in Europe Announced FDA IDE approval to continue enrollment in final phase of the FINALE pivotal trial for FemBloc Announced a definitive agreement for the issuance of $12 million in secured convertible notes and accompanying warrants for total potential funding of $58 million, if all warrants are...

Continue reading

XBP Global Holdings, Inc. Reports Third Quarter 2025 Results

Third Quarter 2025 HighlightsXBP Europe Holdings, Inc. (“XBP Europe”) finalized the acquisition of Exela Technologies BPA, LLC (“Exela BPA”) and changed its name to XBP Global Holdings, Inc. on July 29, 2025 XBP Europe issued approximately 81.8 million shares for an equity valuation of the combined company of $585.7 million, or $4.98/share     Reported revenue1 totaled $209.1 million, a decline of 10.4% year-over-year Combined Pro Forma Revenue2 totaled $220.4 million, a decline of 18.1% year-over-year Gross margin on a reported basis was 22.0%, a 310 basis point increase year-over-year Pro Forma Gross Margin2 of 21.9%, a 190 basis point increase year-over-year Pro Forma Adjusted EBITDA2,3 of $24.7 million, an increase of 7.4% year-over-yearIRVING, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global”...

Continue reading

Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity

BOSTON and ATLANTA, Nov. 14, 2025 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), today reported financial results for the quarter ended September 30, 2025 and highlighted recent developments. “During our third quarter of 2025, we continued to position the Company to advance IKT-001 toward a late-stage clinical trial in PAH,” said Mark Iwicki, Chief Executive Officer of Inhibikase. “We expect to initiate our Phase 2b clinical study of IKT-001, our prodrug of imatinib mesylate, in PAH during the fourth quarter of 2025.” Recent Developments:Advancement of IKT-001 as a therapy in PAH:The proposed Phase 2b IMPROVE-PAH trial is...

Continue reading

Trust Stamp announced filing its 10-Q for Q3-2025 reflecting 71% and 41% increases in Net Recognized Revenue compared to the corresponding three and nine month periods in 2024, and a 17% and 19% decrease in Total Operating Expenses compared to the same periods, with strong growth in customer enrollments and user completions

ATLANTA, Nov. 14, 2025 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI) announced that:It filed its Q3 10-Q report for the nine months ended September 30, 2025 after the Nasdaq market closed on November 14th, 2025. Net recognised revenue for the three months ended September 30, 2025 was $0.87 million, an increase of 71% from $0.51 million for the corresponding period in 2024. An additional $0.23 million of revenue was received from QID and fully earned but subject to deferred recognition under ASC 606. The majority of the increase ($313 thousand) was attributable to the Company’s S&P 500 bank customer resulting from the Company entering into a contract amendment and extension with this customer extending the term until May 31, 2031 (subject to a right for the customer to cancel for convenience on 6 months notice), with...

Continue reading

NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update

CALABASAS, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today announced financial results for the quarter ended September 30, 2025, and provided an update on recent operational achievements and upcoming milestones. Third Quarter & Recent Corporate HighlightsMiddle East – NuroMENA, the UAE-based subsidiary, advanced its regional partnerships by appointing His Highness Sheikh Nahyan bin Zayed Al Nahyan as Executive Chairman, signing a Master Services Agreement with M42’s IROS, and completing ADGM incorporation. The company also progressed a $50 million strategic partnership with Quazar Investment, strengthening Abu Dhabi–US collaboration in...

Continue reading

Viasat to Participate in Deutsche Bank Global Space Summit

CARLSBAD, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced that its Chairman and CEO, Mark Dankberg, and Chief Financial Officer, Gary Chase, will be participating in the Deutsche Bank Global Space Summit, which will be hosted in New York, New York on Wednesday November 19, 2025. Dankberg will take part in the in-person summit on a Direct-to-Device Connectivity panel at 4 p.m. ET alongside other commercial satellite operator leaders. The panel will discuss direct-to-device as the next growth vector for satellite communications through standardization and interoperability with terrestrial connectivity solutions. There will not be a webcast for this in-person event. For specific conference information, or to register to attend the Deutsche Bank Global...

Continue reading

Treasure Global Announces 12-Month Voluntary Lock-Up by Major Shareholders Covering Over 51% of Outstanding Shares

KUALA LUMPUR, Malaysia, Nov. 14, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced that several of its major shareholders have voluntarily committed to a 12-month lock-up covering over 51% of the Company’s outstanding shares, effective November 14, 2025. The lock-up applies to all shares directly or indirectly owned by the participating shareholders, including any securities convertible into or exercisable for Company shares, demonstrating strong confidence in Treasure Global’s long-term strategy and supporting market stability. The participating shareholders include 24 entities and individuals, representing over 51% of the Company’s outstanding shares. Under the agreement, the signatories have pledged not to sell, transfer,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.